NCT04517318View on ClinicalTrials.gov

Treatment After Palbociclib-containing Regimens

CompletedOBSERVATIONAL

Enrollment

200

Participants

Timeline

Start Date

August 15, 2017

Primary Completion Date

April 15, 2021

Study Completion Date

July 15, 2021

Conditions

Breast Cancer

Trial Locations (1)

200032

Fudan University Shanghai Cancer Center, Shanghai

All Listed Sponsors

lead

Fudan University

OTHER

NCT04517318 - Treatment After Palbociclib-containing Regimens | Biotech Hunter | Biotech Hunter